Mostrar el registro sencillo del ítem

dc.contributor.authorAgud, Martin
dc.contributor.authorMedrano, Inés de
dc.contributor.authorMendez-Echevarria, Ana
dc.contributor.authorSainz, Talia
dc.contributor.authorRoman, Federico 
dc.contributor.authorRuiz Carrascoso, Guillermo
dc.contributor.authorEscosa-Garcia, Luis
dc.contributor.authorMolina Amores, Clara
dc.contributor.authorCliment, Francisco José
dc.contributor.authorRodríguez, Aroa
dc.contributor.authorGarcia-Fernandez de Villalta, Marta
dc.contributor.authorCalvo, Cristina
dc.date.accessioned2022-08-05T07:29:15Z
dc.date.available2022-08-05T07:29:15Z
dc.date.issued2022-05-04
dc.identifier.citationSci Rep. 2022 May 4;12(1):7223.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14856
dc.description.abstractTo assess drug-resistant bacterial colonisation rates and associated risk factors in children with complex chronic conditions admitted to a national reference unit in Spain. Cross-sectional study that included all children admitted to our unit from September 2018 to July 2019. Rectal swabs were obtained to determine multidrug-resistant Gram-negative bacilli (MR-GNB) colonisation, and nasal swab to determine S. aureus and methicillin-resistant S. aureus (MRSA) colonisation. Medical records were reviewed. 100 children were included, with a median of four complex chronic conditions. Sixteen percent had S. aureus colonisation, including two MRSA. S. aureus colonisation was associated with technology-dependent children, while being on antibiotic prophylaxis or having undergone antibiotic therapy in the previous month were protective factors. The prevalence of MR-GNB colonisation was 27%, which was associated with immunosuppressive therapy (aOR 31; 2.02-47]; p = 0.01), antibiotic prophylaxis (aOR 4.56; 1.4-14.86; p = 0.012), previously treated skin-infections (aOR 2.9; 1.07-8.14; p = 0.03), surgery in the previous year (aOR 1.4; 1.06-1.8; p = 0.014), and hospital admission in the previous year (aOR 1.79; [1.26-2.56]; p = 0.001). The rate of S. aureus nasal colonisation in this series was not high despite the presence of chronic conditions, and few cases corresponded to MRSA. Antibiotic prophylaxis, immunosuppressive therapies, history of infections, previous surgeries, and length of admission in the previous year were risk factors for MR-GNB colonisation.es_ES
dc.description.sponsorshipThis study was supported by The Spanish Ministry of Science and Innovation –Carlos III Health Institute, and European Regional Development Funds; Grant No. PI18CIII/00372 [Fondo de Investigaciones Sanitarias-Spanish Health Research Fund (ISCIII)]; Grant Award “Jose María Corretger” from the Spanish Society for Paediatric Infectious Diseases; Grant Research Award from the Spanish Association of Paediatric Primary Care; and a small grant award from the European Society for Paediatric Infectious Diseases.es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshMethicillin-Resistant Staphylococcus aureus es_ES
dc.subject.meshStaphylococcal Infections es_ES
dc.subject.meshAnti-Bacterial Agents es_ES
dc.subject.meshCarrier State es_ES
dc.subject.meshChild es_ES
dc.subject.meshChronic Disease es_ES
dc.subject.meshCross-Sectional Studies es_ES
dc.subject.meshGram-Negative Bacteria es_ES
dc.subject.meshHumans es_ES
dc.subject.meshPrevalence es_ES
dc.subject.meshRisk Factors es_ES
dc.subject.meshStaphylococcus aureus es_ES
dc.titleRisk factors for antibiotic-resistant bacteria colonisation in children with chronic complex conditionses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID35508685es_ES
dc.format.volume12es_ES
dc.format.number1es_ES
dc.format.page7223es_ES
dc.identifier.doi10.1038/s41598-022-11295-5es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderEuropean Regional Development Fund es_ES
dc.contributor.funderEuropean Society for Paediatric Infectious Diseases es_ES
dc.contributor.funderSociedad Española de Enfermedades Infecciosas Pediátricas es_ES
dc.contributor.funderAsociación Española de Atención Primaria de Pediatría es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2045-2322es_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41598-022-11295-5es_ES
dc.identifier.journalScientific Reportses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI18CIII/00372es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional